Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
Disease Markers
|
February 14, 2018
Metabolic Footprints and Molecular Subtypes in Breast Cancer
Vera Cappelletti, Egidio Iorio, Patrizia Miodini, et al.
Molecular Oncology
|
July 4, 2017
Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer
Giuseppe Merlino, Patrizia Miodini, Maurizio Callari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2002
Estrogen receptor-beta expression in hereditary breast cancer
Maria Grazia Daidone, Silvia Veneroni, Vera Cappelletti, et al.
Seminars in Cancer Biology
|
April 27, 2017
How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case
Valentina Appierto, Serena Di Cosimo, Carolina Reduzzi, et al.
International Journal of Oncology
|
September 25, 2008
Clusterin: a potential target for improving response to antiestrogens
Sara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 9, 2024
Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients
Carolina Reduzzi, Marta Vismara, Thomas Schamberger, et al.
Journal of the National Cancer Institute
|
April 17, 2003
Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status
Vera Cappelletti, Silvia Veneroni, Danila Coradini, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma
Emanuela Fina, Andrea Necchi, Patrizia Giannatempo, et al.
International Journal of Molecular Sciences
|
January 10, 2018
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
Maurizio Callari, Matteo Dugo, Patrizia Miodini, et al.
International Review of Cell and Molecular Biology
|
September 22, 2023
Can we define breast cancer HER2 status by liquid biopsy?
Serena Di Cosimo, Cinzia De Marco, Marco Silvestri, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
Disease Markers
|
February 14, 2018
Metabolic Footprints and Molecular Subtypes in Breast Cancer
Vera Cappelletti, Egidio Iorio, Patrizia Miodini, et al.
Molecular Oncology
|
July 4, 2017
Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer
Giuseppe Merlino, Patrizia Miodini, Maurizio Callari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2002
Estrogen receptor-beta expression in hereditary breast cancer
Maria Grazia Daidone, Silvia Veneroni, Vera Cappelletti, et al.
Seminars in Cancer Biology
|
April 27, 2017
How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case
Valentina Appierto, Serena Di Cosimo, Carolina Reduzzi, et al.
International Journal of Oncology
|
September 25, 2008
Clusterin: a potential target for improving response to antiestrogens
Sara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 9, 2024
Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients
Carolina Reduzzi, Marta Vismara, Thomas Schamberger, et al.
Journal of the National Cancer Institute
|
April 17, 2003
Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status
Vera Cappelletti, Silvia Veneroni, Danila Coradini, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma
Emanuela Fina, Andrea Necchi, Patrizia Giannatempo, et al.
International Journal of Molecular Sciences
|
January 10, 2018
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
Maurizio Callari, Matteo Dugo, Patrizia Miodini, et al.
International Review of Cell and Molecular Biology
|
September 22, 2023
Can we define breast cancer HER2 status by liquid biopsy?
Serena Di Cosimo, Cinzia De Marco, Marco Silvestri, et al.
Page
of 7